Editors' ChoiceCancer

“CHIP”s are bad for patients with solid tumors

See allHide authors and affiliations

Science Translational Medicine  23 Aug 2017:
Vol. 9, Issue 404, eaao4212
DOI: 10.1126/scitranslmed.aao4212

You are currently viewing the abstract.

View Full Text

Abstract

In patients with nonhematologic cancers, clonal hematopoiesis is prevalent and associated with poor prognoses.

View Full Text